Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      WWE® And The Leukemia & Lymphoma Society (LLS) Join Forces To Help Cancer Patients And Families

      New Partnership Supports LLS's Children's Initiative to address the urgent need for new and better treatments for pediatric cancer patients

      Leukemia & Lymphoma Society logo

      News provided by

      The Leukemia & Lymphoma Society

      Oct 03, 2019, 09:00 ET

      Share this article

      Share this article


      STAMFORD, Conn. and RYE BROOK, N.Y., Oct. 3, 2019 /PRNewswire/ -- WWE and WWE Superstar Roman Reigns are teaming up with The Leukemia & Lymphoma Society (LLS) in the fight against cancer. For Reigns, the cause is personal – he is in remission for the second time from chronic myeloid leukemia (CML). The new partnership with LLS, the world's largest nonprofit fighting blood cancers, will propel the organization's comprehensive effort to drive more research and deliver more assistance to cancer patients and families when they need it most, including those battling pediatric cancer.

      Continue Reading
      WWE AND LLS JOIN FORCES TO HELP CANCER PATIENTS AND FAMILIES
      WWE AND LLS JOIN FORCES TO HELP CANCER PATIENTS AND FAMILIES
      “I know how tough it is to deal with cancer and I want to show people that even someone like me can be knocked down, but with the right treatment and support, we can get back up to fight another day.” - Roman Reigns, WWE Superstar and chronic myeloid leukemia survivor
      “I know how tough it is to deal with cancer and I want to show people that even someone like me can be knocked down, but with the right treatment and support, we can get back up to fight another day.” - Roman Reigns, WWE Superstar and chronic myeloid leukemia survivor
      WWE superstar Roman Reigns joins young cancer survivors for an exclusive behind the scenes experience at the WWE ring
      WWE superstar Roman Reigns joins young cancer survivors for an exclusive behind the scenes experience at the WWE ring

      Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8564553-lls-wwe-roman-reigns-partnership/

      "My own journey with leukemia inspires me to do whatever I can to help young cancer patients. I know how tough it is to deal with cancer and I want to show people that even someone like me can be knocked down, but with the right treatment and support, we can get back up to fight another day," said Reigns. "That's why I'm so honored that WWE and I are helping The Leukemia & Lymphoma Society spread the word about the great work LLS is doing to find new and better treatments for kids and provide financial assistance to families struggling with a cancer diagnosis."

      While progress has been made in finding new treatments and even cures for some cancers, few new, less toxic treatments have been approved for childhood cancers, including leukemia.  LLS recently launched The LLS Children's Initiative to tackle pediatric cancer from every angle by doubling its investment in pediatric research, strengthening patient support services, including back to school resources, family support groups and financial assistance, and advocating for policies that will ensure coverage for treatment and care. As well, LLS will launch a first-of-its-kind clinical trial for pediatric leukemias in 2020. The PedAL Master Clinical Trial is a bold, precision medicine approach to using genomics to target therapies for children.

      According to LLS president and CEO, Louis J. DeGennaro, Ph.D., "LLS was founded 70 years ago by a family for families, and we are honored to partner with WWE and Roman Reigns, who personifies the importance of our mission and our fight to end blood cancers.  We are confident that the tremendous spotlight WWE and Roman shine on our quest for cures will inspire the legions of fans to support LLS and help the thousands of children and families dealing with a cancer diagnosis and treatment."

      Through this partnership, WWE and Reigns will generate awareness and support for research to find new, less toxic treatments for childhood cancers, and LLS's unique educational and support services for patients and families, including financial assistance. WWE will use its global platforms, including TV broadcasts, live events, WWE Network and digital and social media to support LLS's mission. In addition, a portion of sales from select Roman Reigns merchandise will be donated to LLS.

      "WWE is proud to partner with LLS's Children's Initiative and address the need for new and better treatment options for pediatric cancer patients around the world," said Stephanie McMahon, WWE Chief Brand Officer. "Finding a cure for pediatric cancer is critical, we hope by using WWE's platforms and Roman Reigns personal story, we can raise awareness, drive donations, and help inspire patients and families to keep fighting."

      Reigns' personal journey with leukemia began in 2007, when he was diagnosed with CML at age 22. He battled and beat the disease; however; eleven years later, Reigns' cancer returned, and he was forced to relinquish the WWE Universal Championship title and take time away from WWE. After facing down cancer for the second time, Reigns made a heroic return earlier this year. His partnership with LLS is part of his commitment and determination to keep fighting for patients and families. 

      While there have been more than 40 treatments approved by the FDA in the past two and a half years for adults with blood cancer, only four therapies have been approved in the past three decades for first use in children with cancer. And the children who do survive face a lifetime of deadly complications from toxic treatments. Leukemia is the most common cancer diagnosed in children and the second leading cause of cancer death for children. The LLS Children's Initiative addresses the need for more to be done now.

      "As LLS marks its 70th anniversary and more than $1.3 billion invested in research to-date, we are more determined than ever to honor the legacy of our founding family, who lost their 16-year-old son to leukemia.  It's a perfect time to enlist Roman and WWE in our efforts to make an impact for children now," states DeGennaro.

      LLS encourages the public to visit the LLS website to add inspiring stories and photos, along with Reigns' and many  others, to the Generation LLS Family Tree, in recognition of the organization's 70th Anniversary:  https://www.lls.org/generationlls   

      About WWE
      WWE ®, a publicly traded company (NYSE: WWE), is an integrated media organization and recognized leader in global entertainment. The company consists of a portfolio of businesses that create and deliver original content 52 weeks a year to a global audience. WWE is committed to family friendly entertainment on its television programming, pay-per-view, digital media and publishing platforms. WWE's TV-PG, family-friendly programming can be seen in more than 800 million homes worldwide in 28 languages. WWE Network, the first-ever 24/7 over-the-top premium network that includes all live pay-per-views, scheduled programming and a massive video-on-demand library, is currently available in more than 180 countries. The company is headquartered in Stamford, Conn., with offices in New York, Los Angeles, London, Mexico City, Mumbai, Shanghai, Singapore, Dubai, Munich and Tokyo.

      Additional information on WWE (NYSE: WWE) can be found at wwe.com and corporate.wwe.com. For information on our global activities, go to http://www.wwe.com/worldwide/.

      Trademarks:  All WWE programming, talent names, images, likenesses, slogans, wrestling moves, trademarks, logos and copyrights are the exclusive property of WWE and its subsidiaries. All other trademarks, logos and copyrights are the property of their respective owners.

      About The Leukemia & Lymphoma Society
      The Leukemia & Lymphoma Society
      ® (LLS) is the world's largest nonprofit dedicated to fighting blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

      Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.

      For additional information visit lls.org/lls-newsnetwork. Follow us on Facebook, Twitter, and Instagram.

      The Leukemia & Lymphoma Society Contact:

      WWE Contact:

      Kristin Hoose

      Name: Matthew Altman

      Kristin.Hoose@lls.org

      Phone: (203) 352-1177          

      914-821-8973

      Email: Matthew.Altman@wwecorp.com       

      SOURCE The Leukemia & Lymphoma Society

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.